Products
Mutual Funds
Stock Market
NPS Retirement Funds

Company
About us
Contact us
1000005640
Mutual Funds Stock Market NPS Retirement Funds
About us Contact us

NEULAND LAB LTD.

1772.00 +84.35 (5.00%) NSE

Buy Sell

Last updated on 9 Sep 2021 3:31 PM

Returns
(10.77%)
Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

2158.89

Earning Per Share

62.24

Dividend Yield

0.24%

P/E Ratio

33.55

P/B Ratio

2.76

Debt to Equity

0.30

Performance

min-value
max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value
max-value

5.34% down side

up side5.34%


About the company

Set up in 1984 as a private limited company to manufacture bulk drugs, Neuland Laboratories (NLL) is promoted by D R Rao. Neuland Drugs & Pharmaceuticals Pvt Ltd, a company set up by the same promoters to manufacture bulk drugs was merged with NLL with effect from Apr.'92. NLL manufactures bulk drugs such as salbutamol sulphate, terbutaline sulphate, labetalol hydrochloride and ciprofloxacin. It came out with its initial public offering in Apr.'94 at a premium of Rs 35 aggregating Rs 5.69 cr, to part-finance the capacity expansion to manufacture bulk drugs and to diversify its product-mix. The cost of the project as estimated by ICICI was Rs 15.7 cr.

Similar Companies


Login